Join us as we explore the detection of cancer therapy-related cardiac dysfunction (CTRCD) and its…
ideazioFebruary 14, 2025
Bispecific T-cell engagers (BTEs) are novel agents used to treat hematological malignancies. Early trials were…
Amaya SwansonAugust 14, 2024
Older patients with Hodgkin lymphoma (HL) often have comorbid cardiovascular disease; however, the impact of…
Amaya SwansonJuly 11, 2024
Cardiotoxicity Associated With Chimeric Antigen Receptor (CAR)-T Cell Therapy for Hematologic Malignancies: a prospective cohort…
Amaya SwansonJuly 5, 2024
Anthracyclines treat a broad range of cancers. Basic and retrospective clinical data have suggested that…
Amaya SwansonFebruary 15, 2024
